enGene Holdings Inc.·3

Nov 13, 4:00 PM ET

Forbion Capital Fund III Cooperatief U.A. 3

3 · enGene Holdings Inc. · Filed Nov 13, 2023

Insider Transaction Report

Form 3
Period: 2023-10-31
Holdings
  • Class A common shares

    2,894,735
  • Warrant (Right to Buy)

    Exercise: $11.50From: 2023-11-30Exp: 2028-10-31Class A common shares (475,076 underlying)
Footnotes (1)
  • [F1]The securities are held directly by Forbion Capital Fund III Cooperatief U.A. ("Forbion III COOP"). Forbion III Management B.V. ("Forbion III") is the director of Forbion III COOP and disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Documents

1 file
  • 3
    ownership.xmlPrimary

    3